GlaxoSmithKline is in a spree of producing new diabetes and cancer drugs which it hopes will increase its sales this year. After the recent U.S. drug approvals it is starting to market two of its ...
GSK's new price cap applies to both of those products and the rest of its asthma ... at
[email protected].
The furore over Avandia (rosiglitazone), GlaxoSmithKline's blockbuster drug for diabetes, illustrates how ... Agency for the Evaluation of Medicinal Products (EMEA) moved more quickly, and in ...